Product image of Irbesartan Actavis (Irbesartan) supplied by GNH India

Irbesartan Actavis

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Actavis (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Actavis, is an angiotensin II receptor blocker (ARB) presented as an oral tablet for systemic use. It lowers elevated blood pressure and slows progression of kidney damage in patients with diabetes, acting by selectively inhibiting angiotensin II type 1 receptors. The medication is indicated for adults with primary hypertension and for those with diabetic nephropathy, providing a targeted approach to cardiovascular and renal protection.

GNH India supplies Irbesartan Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Actavis Group Ptc Ehf.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Irbesartan is used to manage conditions related to the renin‑angiotensin system, primarily hypertension and diabetic kidney disease.
  • Hypertension: lowers systolic and diastolic blood pressure, reducing the risk of stroke, myocardial infarction, and other cardiovascular events.
  • Diabetic nephropathy: slows the decline of renal function in patients with type 2 diabetes, helping to preserve kidney health.

How It Works

  • Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors located on vascular smooth muscle, adrenal gland, and renal tubular cells. By blocking AT1 activation, it prevents vasoconstriction, aldosterone release, and sodium‑water retention, leading to vasodilation, reduced blood volume, and lowered arterial pressure. The blockade also attenuates pathological remodeling of the heart and blood vessels, contributing to long‑term cardiovascular protection. These pharmacodynamic actions make irbesartan effective in both blood pressure control and renal protection.

Side Effects

Irbesartan may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate pain in the head region.
  • Fatigue: unusual tiredness or lack of energy.
  • Upper respiratory tract infection: symptoms such as sore throat, nasal congestion, or cough.
  • Nausea: feeling of sickness in the stomach.
  • Diarrhea: loose, watery stools.

Serious or Rare Side Effects

  • Hyperkalemia: elevated blood potassium that can affect heart rhythm.
  • Angioedema: swelling of the face, lips, tongue, or throat, potentially compromising airway.
  • Acute renal failure: sudden loss of kidney function requiring medical attention.
  • Hypotension: marked drop in blood pressure leading to faintness.

Precautions & Warnings

When prescribing irbesartan, clinicians should consider several precautionary measures to ensure safe use.

  • Renal function: assess baseline creatinine and monitor periodically.
  • Electrolytes: check serum potassium before initiation and during therapy.
  • Pregnancy: avoid use in the second and third trimesters due to potential fetal harm.
  • Concomitant drugs: review for potassium‑sparing agents or NSAIDs that may increase adverse effects.
  • Hypersensitivity: discontinue if signs of angioedema or rash appear.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Avoid Interactions

Irbesartan can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalaemia.
  • ACE inhibitors or other ARBs: additive blood pressure lowering, possible renal impairment.
  • Aliskiren in diabetic patients: increased risk of renal dysfunction and hyperkalaemia.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive effect and affect renal function.
  • Lithium: may increase lithium levels; monitor for toxicity.
  • Cyclosporine: can raise irbesartan concentrations; monitor blood pressure and renal function.

Frequently Asked Questions

Irbesartan Actavis is prescribed to treat primary hypertension and to slow the progression of diabetic nephropathy. By lowering blood pressure and reducing renal stress, it helps protect cardiovascular health and preserve kidney function in adults with these conditions.

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors on blood vessels, adrenal glands, and kidney cells. This inhibition prevents vasoconstriction, aldosterone release, and sodium‑water retention, resulting in vasodilation, reduced blood volume, and lower arterial pressure.

The appropriate dose of Irbesartan Actavis is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Irbesartan is generally contraindicated during the second and third trimesters of pregnancy because it may cause fetal harm. Safety during breastfeeding has not been fully established, so clinicians usually advise against its use unless the potential benefit outweighs the risk.

To order Irbesartan Actavis, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with ACE inhibitors, Irbesartan offers a similar blood‑pressure‑lowering effect but with a lower incidence of cough. Unlike calcium‑channel blockers, it directly targets the renin‑angiotensin system, providing additional renal protective benefits, especially in patients with diabetic kidney disease.

Irbesartan Actavis tablets should be stored at ambient temperature, preferably below 25 °C, in their original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Irbesartan Actavis is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should not crush or chew the tablet unless specifically instructed by a healthcare professional.

The most serious risks include hyperkalaemia, which can cause cardiac arrhythmias, angioedema that may threaten the airway, and acute renal failure, especially when combined with other drugs that affect kidney function. Prompt medical attention is required if any of these symptoms occur.

Irbesartan should not be used by individuals with known hypersensitivity to the drug or any component of the formulation, patients with severe hepatic impairment, or those who are pregnant in the second or third trimester. Caution is also advised for patients with significant renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT